These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 23167600

  • 1. Sirolimus inhibits lymphangiogenesis in rat renal allografts, a novel mechanism to prevent chronic kidney allograft injury.
    Palin NK, Savikko J, Koskinen PK.
    Transpl Int; 2013 Feb; 26(2):195-205. PubMed ID: 23167600
    [Abstract] [Full Text] [Related]

  • 2. Sirolimus attenuates chronic allograft nephropathy in an experimental rat kidney transplantation model.
    Savikko J, von Willebrand E.
    Transplant Proc; 2006 Oct; 38(8):2699-700. PubMed ID: 17098043
    [Abstract] [Full Text] [Related]

  • 3. Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction.
    Ko HT, Yin JL, Wyburn K, Wu H, Eris JM, Hambly BD, Chadban SJ.
    Nephrol Dial Transplant; 2013 Feb; 28(2):327-36. PubMed ID: 23229928
    [Abstract] [Full Text] [Related]

  • 4. Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis.
    Krebs R, Tikkanen JM, Ropponen JO, Jeltsch M, Jokinen JJ, Ylä-Herttuala S, Nykänen AI, Lemström KB.
    Am J Pathol; 2012 Nov; 181(5):1607-20. PubMed ID: 22959907
    [Abstract] [Full Text] [Related]

  • 5. Early short-term platelet-derived growth factor inhibition prevents the development of chronic allograft nephropathy in experimental rat kidney transplantation.
    Savikko J, Rintala J, von Willebrand E.
    Transplant Proc; 2006 Dec; 38(10):3231-2. PubMed ID: 17175231
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection.
    Rintala SE, Savikko J, Rintala JM, von Willebrand E.
    Transplant Proc; 2006 Dec; 38(10):3236-8. PubMed ID: 17175233
    [Abstract] [Full Text] [Related]

  • 7. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM, Savikko J, Rintala SE, von Willebrand E.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor in chronic rat allograft nephropathy.
    Malmström NK, Kallio EA, Rintala JM, Nykänen AI, Räisänen-Sokolowski AK, Paavonen T, Lemström KB, Koskinen PK.
    Transpl Immunol; 2008 May; 19(2):136-44. PubMed ID: 18503889
    [Abstract] [Full Text] [Related]

  • 9. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
    Savikko J, Taskinen E, Von Willebrand E.
    Transplantation; 2003 Apr 27; 75(8):1147-53. PubMed ID: 12717194
    [Abstract] [Full Text] [Related]

  • 10. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM, Savikko J, Rintala SE, von Willebrand E.
    Transplant Proc; 2006 Dec 27; 38(10):3239-40. PubMed ID: 17175234
    [Abstract] [Full Text] [Related]

  • 11. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 12. Oral Platelet-Derived Growth Factor and Vascular Endothelial Growth Factor Inhibitor Sunitinib Prevents Chronic Allograft Injury in Experimental Kidney Transplantation Model.
    Rintala JM, Savikko J, Palin N, Rintala SE, Koskinen PK, von Willebrand E.
    Transplantation; 2016 Jan 15; 100(1):103-10. PubMed ID: 26262503
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor inhibition, a novel pathway to prevent chronic allograft injury.
    Rintala JM, Savikko J, Palin N, Rintala SE, Koskinen PK, von Willebrand E.
    Transplantation; 2014 Oct 27; 98(8):821-7. PubMed ID: 25073034
    [Abstract] [Full Text] [Related]

  • 14. Rapamycin and cyclosporine have different effects on expression of Ang-1 and Ang-2 and Tie2 in rat renal allograft with chronic allograft nephropathy.
    Ma X, Lu YP, Yang L, Song J, Luo GH, Shi YJ, Li YP.
    Transplant Proc; 2008 Oct 27; 40(8):2804-7. PubMed ID: 18929866
    [Abstract] [Full Text] [Related]

  • 15. Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients.
    Stallone G, Di Paolo S, Schena A, Infante B, Grandaliano G, Battaglia M, Gesualdo L, Schena FP.
    Transplantation; 2003 Apr 15; 75(7):998-1003. PubMed ID: 12698087
    [Abstract] [Full Text] [Related]

  • 16. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.
    Nykänen AI, Sandelin H, Krebs R, Keränen MA, Tuuminen R, Kärpänen T, Wu Y, Pytowski B, Koskinen PK, Ylä-Herttuala S, Alitalo K, Lemström KB.
    Circulation; 2010 Mar 30; 121(12):1413-22. PubMed ID: 20231530
    [Abstract] [Full Text] [Related]

  • 17. Conversion to sirolimus allows preservation of renal function in kidney and kidney-pancreas allograft recipients.
    Laham G, Sleiman S, Soler Pujol G, Diaz C, Dávalos M, Vilches A.
    Transplant Proc; 2010 Mar 30; 42(1):309-13. PubMed ID: 20172338
    [Abstract] [Full Text] [Related]

  • 18. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury.
    Fuller TF, Freise CE, Serkova N, Niemann CU, Olson JL, Feng S.
    Transplantation; 2003 Dec 15; 76(11):1594-9. PubMed ID: 14702530
    [Abstract] [Full Text] [Related]

  • 19. The effect of sirolimus in the development of chronic allograft nephropathy.
    Gürkan A, Kaçar S, Erdoğdu U, Varilsüha C, Kandemir G, Karaca C, Akman F.
    Transplant Proc; 2008 Dec 15; 40(1):114-6. PubMed ID: 18261561
    [Abstract] [Full Text] [Related]

  • 20. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov 15; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.